Morioka Hiroshi, Yanagisawa Naoki, Sasaki Shugo, Sekiya Noritaka, Suganuma Akihiko, Imamura Akifumi, Ajisawa Atsushi, Kishida Shuji
Department of Infectious Diseases, Nagoya University Hospital, Japan.
Intern Med. 2016;55(10):1383-6. doi: 10.2169/internalmedicine.55.5783. Epub 2016 May 15.
We herein report a 52-year-old man infected with human immunodeficiency virus (HIV) who was referred to our hospital due to the development of severe neurocognitive disorders and bilateral leukoencephalopathy. He has been treated with antiretroviral agents for 17 years, but low-level viremia has been detected consistently prior to admission. Drug resistant testing of the serum and the cerebrospinal fluid (CSF) both demonstrated a M184V mutation. A brain biopsy revealed perivascular CD8(+) T-lymphocyte infiltration, leading to the diagnosis of CD8 encephalitis. The clinical symptoms improved drastically after changing to a nucleoside reverse transcriptase inhibitor sparing regimen, which subsequently decreased the HIV viral load to an undetectable level in both the serum and CSF.
我们在此报告一名52岁感染人类免疫缺陷病毒(HIV)的男性,因其出现严重神经认知障碍和双侧白质脑病而转诊至我院。他接受抗逆转录病毒药物治疗已达17年,但入院前一直检测到低水平病毒血症。血清和脑脊液(CSF)的耐药性检测均显示存在M184V突变。脑活检显示血管周围CD8(+) T淋巴细胞浸润,从而诊断为CD8脑炎。改用不含核苷类逆转录酶抑制剂的治疗方案后,临床症状大幅改善,随后血清和脑脊液中的HIV病毒载量均降至无法检测到的水平。